These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18452378)

  • 1. Easypod: a new electronic injection device for growth hormone.
    Dahlgren J
    Expert Rev Med Devices; 2008 May; 5(3):297-304. PubMed ID: 18452378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. User trial of Easypod, an electronic autoinjector for growth hormone.
    Tauber M; Payen C; Cartault A; Jouret B; Edouard T; Roger D
    Ann Endocrinol (Paris); 2008 Dec; 69(6):511-6. PubMed ID: 18589398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of injection dose force, accuracy and precision among three growth hormone injection devices.
    Kappelgaard AM; Hansen NÅ
    Expert Rev Med Devices; 2013 May; 10(3):321-7. PubMed ID: 23560872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.
    Su PH; Yang C; Chao MC; Chiang CL
    JMIR Pediatr Parent; 2021 Jan; 4(1):e14774. PubMed ID: 33448936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of Adherence Monitoring in Adult Patients With Growth Hormone Deficiency Under Replacement Therapy: Preliminary Monocentric Data With Easypod
    Mancini A; Vergani E; Bruno C; Palladino A; Brunetti A
    Front Endocrinol (Lausanne); 2019; 10():416. PubMed ID: 31316468
    [No Abstract]   [Full Text] [Related]  

  • 7. Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed methods feasibility study.
    Stokes H; Jones J; Worth C; Nicholson J; Fullwood C; Banerjee I
    Front Endocrinol (Lausanne); 2023; 14():1167854. PubMed ID: 37324260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient experience with a new teriparatide delivery device.
    Dore RK; Feldman RG; Taylor KA; See K; Dalsky GP; Warner MR
    Curr Med Res Opin; 2009 Oct; 25(10):2413-22. PubMed ID: 19656016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay.
    Meinhardt U; Eiholzer U; Seitz L; Bøgelund M; Kappelgaard AM
    Expert Rev Med Devices; 2014 Jan; 11(1):31-8. PubMed ID: 24308742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A history of growth hormone injection devices.
    Fidotti E
    J Pediatr Endocrinol Metab; 2001 May; 14(5):497-501. PubMed ID: 11393569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone available.
    Posit Aware; 1995; ():5. PubMed ID: 11362568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone delivery devices: current features and potential for enhanced treatment adherence.
    Rohrer TR; Horikawa R; Kappelgaard AM
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1253-1264. PubMed ID: 27718757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?
    Lugaresi A
    Expert Opin Drug Deliv; 2009 Sep; 6(9):995-1002. PubMed ID: 19637982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence and long-term growth outcomes: results from the easypod
    Koledova E; Stoyanov G; Ovbude L; Davies PSW
    Endocr Connect; 2018 Aug; 7(8):914-923. PubMed ID: 29976785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hold the device against the skin: the impact of injection duration on user's force for handheld autoinjectors.
    Schneider A; Mueller P; Jordi C; Richard P; Sneeringer P; Nayyar R; Yovanoff M; Lange J
    Expert Opin Drug Deliv; 2020 Feb; 17(2):225-236. PubMed ID: 31835921
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use.
    Dahlgren J; Veimo D; Johansson L; Bech I
    Curr Med Res Opin; 2007 Jul; 23(7):1649-55. PubMed ID: 17559757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis.
    Chader GJ; Weiland J; Humayun MS
    Prog Brain Res; 2009; 175():317-32. PubMed ID: 19660665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiment on a novel user input for computer interface utilizing tongue input for the severely disabled.
    Kencana AP; Heng J
    Disabil Rehabil Assist Technol; 2008 Nov; 3(6):351-9. PubMed ID: 19117196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain behaviour and distress in children during two sequential dental visits: comparing a computerised anaesthesia delivery system and a traditional syringe.
    Versloot J; Veerkamp JS; Hoogstraten J
    Br Dent J; 2008 Jul; 205(1):E2; discussion 30-1. PubMed ID: 18493254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.